ArticleInternational journal of clinical pharmacy2024

Cost-effectiveness analysis of PD-1 inhibitors as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma in China: an economic evaluation based on network meta-analysis.

Shuang Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.